Vaccine: The dating platform opens for 60-64 and 70-79 years | HELLAS



[ad_1]

The dating platform for coronavirus vaccination for age groups 60-64 and 70-79 opens immediately.

RELEVANT ARTICLES

Coronavirus: Safe AstraZeneca Vaccine – Why 3 Months for Second Dose

Peloni: Vaccines for people ages 60-64 start with AstraZeneca vaccine in mid-February

Specifically, as announced by Marios Themistocleous, on Wednesday, February 10, the dating platform for people from 60 to 64 years old with the Astra Zeneca vaccine opens. Your vaccination will begin on February 15. While, as underlined, vaccination centers will open in which only AstraZeneca vaccines will be administered.

As for age group 70-79 years, the platform will open on Friday February 12 and vaccinations will begin on February 15, as announced by Deputy Government Representative Aristotle Peloni earlier in the briefing. Marios Themistokleous announced that additional centers will be opened in Athens and Thessaloniki that will support these appointments.

“We received the first deliveries from AstraZeneca”

The Secretary General of Primary Health Care, Marios Themistokleous, announced today that the first 40,000 doses of the AstraZeneca vaccine were received on Sunday, while vaccination coverage in the country now stands at 4.9%. To date, 410,000 citizens have been vaccinated in Greece.

Mr. Themistocleous also highlighted that after vaccinating people aged 60-64 with the AstraZeneca vaccine, the platform will open for appointments of citizens aged 18-60 with underlying diseases, so that they can be vaccinated.

Responding to a question about the possibility of needing a third dose of vaccine in the fall, to deal with mutations, Maria Theodoridou pointed out that for the moment this is all in the realm of fantasy. The chairman of the vaccination committee noted that the data is observed and in case of a decrease in antibodies, such a thing can be suggested.

In addition, the chair of the vaccination committee noted that the pharmaceutical industry is investigating the possibility of creating multivalent vaccines or a combination of such vaccines to treat mutations, if necessary. Ms Theodoridou stressed, however, that all this is still at the level of theoretical discussion.

Follow iefimerida.gr on Google News and be the first to know all the news

See all the latest news from Greece and the world, at iefimerida.gr



[ad_2]